{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:20:16Z","timestamp":1786990816941,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ijrobp.2021.08.033","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T19:50:55Z","timestamp":1630353055000},"page":"379-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2208-3241","authenticated-orcid":false,"given":"Lauren E.","family":"Henke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessika A.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Curcuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Stewart","family":"Massad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Fuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premal","family":"Thaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Markovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perry W.","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Chundury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.08.033_bib0001","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1200\/JCO.2014.55.1713","article-title":"Prognosis and conditional disease-free survival among patients with ovarian cancer","volume":"32","author":"Kurta","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0002","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0003","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1006\/gyno.2001.6199","article-title":"Quality of life in ovarian cancer patients receiving chemotherapy","volume":"81","author":"Lakusta","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0004","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/1097-0142(19860815)58:4<880::AID-CNCR2820580413>3.0.CO;2-Z","article-title":"Salvage therapy with whole-abdominal irradiation in patients with advanced carcinoma of the ovary previously treated by combination chemotherapy","volume":"58","author":"Peters","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0005","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2016.02.005","article-title":"Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy","volume":"141","author":"Chundury","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0006","volume":"36","author":"Coleman","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0007","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2006.09.7469","article-title":"Stereotactic body radiation therapy in multiple organ sites","volume":"25","author":"Timmerman","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0008","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0009","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00249","article-title":"Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy","volume":"6","author":"Hasan","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0012","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ijrobp.2018.03.058","article-title":"Stereotactic body radiation therapy for oligometastatic ovarian cancer: A step toward a drug holiday","volume":"101","author":"Lazzari","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0013","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/IGC.0000000000001324","article-title":"Stereotactic body radiation therapy in oligometastatic ovarian cancer: A promising therapeutic approach","volume":"28","author":"Iftode","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0014","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijrobp.2015.02.016","article-title":"Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy","volume":"92","author":"Pollom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0015","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","article-title":"Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer","volume":"24","author":"Timmerman","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0017","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.clon.2018.08.010","article-title":"Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A 4.5-Year Clinical Experience","volume":"30","author":"Henke","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0018","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1002\/mp.13002","article-title":"First clinical implementation of real-time, real anatomy tracking and radiation beam control","volume":"45","author":"Green","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2015.10.015","article-title":"Online magnetic resonance image guided adaptive radiation therapy: first clinical applications","volume":"94","author":"Acharya","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0021","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ijrobp.2015.02.057","article-title":"Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a 60Co Magnetic Resonance Image Guidance Radiation Therapy System","volume":"92","author":"Wooten","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0022","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1118\/1.4930249","article-title":"Characterization of the onboard imaging unit for the first clinical magnetic resonance image guided radiation therapy system","volume":"42","author":"Hu","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0023","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1118\/1.4930249","article-title":"Characterization of the onboard imaging unit for the first clinical magnetic resonance image guided radiation therapy system","volume":"42","author":"Hu","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phro.2019.02.002","article-title":"Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer","volume":"9","author":"Tetar","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brachy.2014.01.004","article-title":"Implant time and process efficiency for CT-guided high-dose-rate brachytherapy for cervical cancer","volume":"13","author":"Mayadev","year":"2014","journal-title":"Brachyther"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phro.2020.12.004","article-title":"Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region","volume":"17","author":"Sibolt","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0027","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/02841860600904854","article-title":"Phase II study on stereotactic body radiotherapy of colorectal metastases","volume":"45","author":"Hoyer","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0029","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1200\/JCO.1997.15.6.2183","article-title":"Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer","volume":"15","author":"Bokkel Huinink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ijrobp.2017.06.2465","article-title":"adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer (International Federation of Gynecology and Obstetrics Stage III): First results of a prospective phase 2 study","volume":"99","author":"Arians","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0031","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ijrobp.2016.08.006","article-title":"Magnetic resonance image guided radiation therapy for external beam accelerated partial-breast irradiation: Evaluation of delivered dose and intrafractional cavity motion","volume":"96","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0032","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.572564","article-title":"Stereotactic body radiation therapy: A versatile, well-tolerated, and effective treatment option for extracranial metastases from primary ovarian and uterine cancer","volume":"10","author":"Aghdam","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0034","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1634\/theoncologist.2019-0309","article-title":"A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): A collaboration of MITO, AIRO GYN, and MaNGO groups","volume":"25","author":"Macchia","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0035","first-page":"415","article-title":"Stereotactic radiotherapy in recurrent gynecological cancer: A case series","volume":"22","author":"Deodato","year":"2009","journal-title":"Oncol Reports"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0036","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2018.08.012","article-title":"Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial","volume":"151","author":"Chang","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0037","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2013.04.469","article-title":"Involved-field radiation therapy for locoregionally recurrent ovarian cancer","volume":"130","author":"Brown","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0038","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ygyno.2018.11.017","article-title":"Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028","volume":"152","author":"Varga","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0039","first-page":"1","article-title":"Single-arm phases 1 and 2 trial of niraparib in combination with pembrolizumab in patients with recurrent platinum-resistant ovarian carcinoma","author":"Konstantinopoulos","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0040","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMoa1611310","article-title":"Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer","volume":"375","author":"Mirza","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0041","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in Stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2021.08.033_bib0042","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: A Paradigm Shift","volume":"105","author":"Formenti","year":"2013","journal-title":"J Natl Cancer Inst"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621027267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621027267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:58:06Z","timestamp":1759744686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621027267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0360301621027267"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.08.033","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}